11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      SUN-264 Mutations in the Maternally Imprinted Genes, MKRN3 and DLK1, Associated with Central Precocious Puberty

      abstract

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Context: Central precocious puberty (CPP) results from premature activation of the hypothalamic–pituitary–gonadal axis. Loss-of-function mutations in makorin ring finger 3 ( MKRN3), a maternally imprinted gene, have been recognized as the most common genetic cause of CPP. More recently, a complex defect (deletion and duplication) in delta-like 1 homolog ( DLK1), another maternally imprinted gene, was associated with CPP and increased body fat in a family with several affected girls. Single nucleotide polymorphisms in or near the MKRN 3 and DLK1 genes have been associated with age of menarche when the variant is inherited from the father. Objectives: To investigate the prevalence of mutations in MKRN3 and DLK1 in a cohort of 50 patients (3 boys) with CPP. Design: The 5’ untranslated region (5’UTR) and coding regions of MKRN3 and DLK1 were amplified and sequenced by Sanger sequencing. Family members of patients with identified MKRN3 or DLK1 variants were included for genetic analysis when DNA was available. Results: We identified five mutations in MKRN3: four novel missense (p.Tyr117Cys, p.Ile461Phe, p.Met126Val and p.Cys364Phe), and one rare frameshift mutations (p.Ala288Profs*108, gnomADE frequency 8e-06). These mutations were identified in five girls, two of whom had a family history of CPP. The Cys364Phe mutation, located in a key cysteine residue in the E3 ligase RING finger domain of MKRN3, was identified in a proband and her paternal cousin with CPP. Ala288Profs*108 was identified in a proband and in two affected relatives, her sister and a paternal cousin. The patient’s father also harbored the mutation; he did not have known early pubertal development. The fathers of the two girls with Ile461Phe and Met126Val mutations without a known family history of CPP were sequenced and harbored the corresponding mutations. In addition, one homozygous variant was identified in the 5’UTR of DLK1, c.-217G>T, in an overweight girl without a family history of CPP. This variant has been reported in the heterozygous state at a frequency of 3e-05 in gnomADE. Her father was not available for genetic studies. Interestingly, her mother was homozygous for the wild type allele, suggesting that the mother did not transmit a DLK1 allele to the patient in this region. All patients with mutations had classical features of CPP. Conclusions: In our cohort of CPP, 10% of subjects had MKRN3 mutations. Familial segregation analysis was performed in four cases and in all cases the mutations were paternally inherited. A nucleotide change was identified in the 5’UTR of DLK1 in a girl with CPP. While there are other less likely possibilities, the absence of the variant in her mother’s sequence suggests that the mutation was inherited from her father in duplicate (uniparental disomy). Our findings support a role for imprinted genes in regulating the timing of pubertal development.

          Related collections

          Author and article information

          Journal
          J Endocr Soc
          J Endocr Soc
          jes
          Journal of the Endocrine Society
          Endocrine Society (Washington, DC )
          2472-1972
          15 April 2019
          30 April 2019
          : 3
          : Suppl 1 , ENDO 2019 Abstracts - 101st Annual Meeting of the Endocrine Society – March 23 – 26th, 2019 – New Orleans, Louisiana
          : SUN-264
          Affiliations
          [_1]Boston Children's Hospital, West Roxbury, MA, United States
          [_2]Brigham and Women's Hospital, Division of Endocrinology, Diabetes and Hypertension/Harvard Medical School, Boston, MA, United States
          [_3]Dept. of Endocrinology, Brigham and Women's Hospital, Division of Endocrinology, Diabetes and Hypertension/Harvard Medical School, Boston, MA, United States
          [_4]Division of Endocrinology, Brigham and Women's Hospital, Division of Endocrinology, Diabetes and Hypertension/Harvard Medical School, Boston, MA, United States
          [_5]Nemours Children's Health System, Jacksonville, FL, United States
          [_6]Div of Endo, Nemours Children's Health System, Jacksonville, FL, United States
          [_7]Sao Paulo Medical School, Sao Paulo University, Sao Paulo, , Brazil
          [_8]Trakya University Faculty of Medicine, Istanbul, , Turkey
          [_9]University of Brasilia, Brasilia, , Brazil
          Article
          js.2019-SUN-264
          10.1210/js.2019-SUN-264
          6553159
          ac3fc6b2-2232-46d2-b0a7-9acec5d307c9
          Copyright © 2019 Endocrine Society

          This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).

          History
          Categories
          Pediatric Endocrinology
          Pediatric Transgender Medicine, Growth Disorders, and Puberty

          Comments

          Comment on this article